As the FDA weighs its first psychedelic approval, Sarah Norman, MPP, says training, credentialing, and reimbursement are lagging while patients are already asking.
Sarah Norman, MPP
Advertisement
Sarah Norman, MPP, executive director of BrainFutures.
Articles by Sarah Norman, MPP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
The Case for Routine Kidney Screening, With Pranav Garimella, MBBS, MPH
2
Anti-Alpha-Gal Antibodies Block IgE Binding in Alpha-Gal Syndrome
3
Nearly 9 in 10 US Adults With CKD Don't Know They Have It, With Pranav Garimella
4
Weekly Insulin Efsitora Alfa (Onswik) Gains FDA approval for Type 2 Diabetes
5